期刊文献+

互为内标法测定患者血浆中氟西汀和西酞普兰的浓度 被引量:3

Determination of Fluoxetine and Citalopram in Patient Plasma Using Each Internal Standard Method by HPLC
下载PDF
导出
摘要 目的:建立测定人血浆中氟西汀、西酞普兰的高效液相色谱-荧光(HPLC-FLU)法,为临床用药提供参考。方法:氟西汀和西酞普兰互为内标,血浆样品碱化后经液-液萃取,以Ultimate XB-C18反相色谱柱进行分离,流动相为乙腈:0.02 mol·L-1磷酸氢二钠溶液(35∶65,pH 5.0),流速为1.0 ml·min-1,柱温为30℃。荧光检测氟西汀和西酞普兰的激发波长为230nm,发射波长为305 nm。结果:氟西汀、西酞普兰血药浓度均在15.625~1 000μg.L-1范围内线性关系良好;平均回收率分别为100.72%和100.94%;分析方法的最低定量限均为5μg.L-1;日内、日间RSD均<3%;冻融稳定性RSD均<10%。结论:本法快速、简便、灵敏、准确,适用于氟西汀、西酞普兰的血药浓度监测及药动学研究。 Objective: To establish an HPLC method with fluorescence detection assay for the determination of fluoxetine and citalopram in the patient plasma and provide a scientific basis for the clinical application.Method: Fluoxetine and citalopram were used as the internal standard for each other.The samples were alkalized and extracted by liquid-liquid extraction.Then the samples were separated on an Ultimate XB-C18 column with the mixture of acetonitrile-0.02 mol·L-1 disodium hydrogen phosphate(35∶ 65,pH 5.0) as the mobile phase.The flow rate was 1.0 ml·min-1.The column temperature was set at 30℃.Fluoxetine and citalopram were detected by fluorescence detection(Ex=230 nm,Em=305 nm).Result: Linearity was obtained from 15.625 to 1 000 μg·L-1 for fluoxetine and citalopram.The LOQ was 5 μg·L-1.The average recovery of fluoxetine and citalopram was 100.72% and 100.94%,respectively.Both the inter-day and intra-day RSD were less than 3%.The Freeze-thaw stability RSD was less than 10%.Conclusion: The method is rapid,convenient,sensitive and reliable in the drug determination,adverse reaction control and pharmacokinetic study of fluxetine and citalopram in human plasma.
出处 《中国药师》 CAS 2012年第10期1431-1434,共4页 China Pharmacist
关键词 高效液相色谱-荧光法 氟西汀 西酞普兰 血药浓度 HPLC-FLU Fluoxetine Citalopram Plasma drug concentration
  • 相关文献

参考文献9

  • 1杨宝峰.药理学[M].第7版.北京:人民卫生出版社,2008:135-136.
  • 2周帆,辛华雯.药物基因组学与个体化治疗[J].中国药师,2011,14(11):1673-1677. 被引量:4
  • 3Scordo MG, Spina E, Dahl ML, et al. Influence of CYP2 C9,2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fiuoxetine and norfluoxetine [ J ]. Basic Clin Pharmacol Toxicol, 2005,97 ( 5 ) : 296 -301.
  • 4Salvador F,Alberto MB,Enrique P,et al. Evaluation of the influence of sex and CYP2C19 and CYP2D6 citalopram [ J ]. European Journal 200-204 polymorphisms in the disposition of of Pharmacology, 2010,626 ( 2 ) :.
  • 5刘昭前,王久辉,周宏灏.氟西汀的药代动力学及其与CYP450酶的作用[J].中国药理学通报,2000,16(6):618-620. 被引量:15
  • 6Carlsson B,Holmgren A,Anlner J,et al. Enantiosepeetive analysis of citalopram and escitalopram in postmortem blood together with genoty- ping for CYP2D6 and CYP2 C19 [ J ]. J Anal Toxicol, 2009,33 ( 2 ) : 65 -76.
  • 7Mrazek DA, Biernacka JM, O'Kane D J, et al. CYP2C 19 variation and citalopram response [ J ]. Pharmacogenet Genomics, 2011,21 ( 1 ) : 1-9.
  • 8He J,Zhou ZL,Li HD. Simultaneous determination of fluoxetine,cita- lopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography - electrospray ionization mass spectrometry (HPLC- MS/ESI) [ J 1. Journal of Chromatography B, 2005,820 ( 1 ) : 33-39.
  • 9魏世杰,文友民,党宏万,杨小英,贾乐川,孙维红,徐卫国.HPLC-荧光法同时测定人血浆中3种抗抑郁药的浓度[J].中国药房,2009,20(26):2026-2028. 被引量:3

二级参考文献38

  • 1何娟,周志凌,李焕德.HPLC-MS同时测定4种新型抗抑郁药物的血药浓度[J].药物分析杂志,2005,25(12):1428-1432. 被引量:16
  • 2Jeppesen U, Gram LF, Vistisen K, et al. Dose-dependent inhibition of CYPIA2, CYP2C19 ana CYP2D6 by eitalopram, fluoxetine, fluvoxamine and paroxetine [J ]. Eur Clin Pharmacol, 1996, 51(1) : 73.
  • 3Ryan LV, Daiga H, Lawrence A, et al .Rapid determination of venlafaxine and o - desmethyvenlafaxine in human plasma by high- performance liquid chromatography with fluorimetric detection[J]. Chrornatogr B, 1997,703(1): 195.
  • 4Shin .IG, Kim KA, Yoon YR, et al. Rapid simple high- performanace liquid chromatographic determination of paroxetine in human plasma[J ] . J Chromatogr B, 1998,713(2):452.
  • 5Kristoffersen L, Bugge A, Lundanes E, et al . Simultaneous determination of citalopram,fluoxetine, paroxetine and their metabolites in plasma and whole blood by high performance liquid chromatography with ultraviolet and fluorescence detection[J]. J Chromatogr B Biomed Sci Appl, 1999,734(2):229.
  • 6Ahshuler D, Brooks LD. Chakravarti A, et al. A haplotype map of the human genome [ J ]. Nature,2005,437 (7063) : 1299-320.
  • 7Marshall A. Genset-Abbott deal heralds pharmaeyogenomies era [ J ]. Nat biotechnol ,1997 ,15 ( 9 ) :829-30.
  • 8Antonico R. Inventing the pharmacogenomics business [ J ]. Am J Health Syst Phatm, 1999,56 ( 1 ) :40 -50.
  • 9William E. E, Mary VR. Pharmacogenomics : translating functional ge- nornics into rational therapeutics [ J ]. Science, 1999,286 ( 487 ) :487- 491.
  • 10Romkes M, Buch SC. Genetyping technologies:application to biotrans- formation enzyme genetic polymorphism screening [ J ]. Methods Mol Biol ,2005 ,291: 399-414.

共引文献108

同被引文献16

  • 1Li H, Li T, Li G, et al. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials2J~. Ann Clin Psychiatry,2014,26(4) ~281-287.
  • 2Beaune S, Callebert J, Baud FJ, et ai. Mechanisms of high-dose eitalopram induced death in a rat model[J]. Toxicology, 2012, 302 (2/3) : 248-254.
  • 3Oransay K, Hocaoglu N, Buyukdeligoz M, et al. The role of adenosine receptors and endogenous adenosine in citalopram- induced cardiovascular toxicity[J]. Indian J Pharmacol, 2014,46 (4) :378-385.
  • 4Ji Y, Schaid DJ, Desta ZJ, et al. Citalopram and escitalopram plasma drug and metabolite concentrations: genome wide associations[J]. Br J Ciin Pharmaco|, 2014,78(2) : 373-383.
  • 5Chang M, Tyhring G, Dahl ML, et al. Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis[J]. Clin Pharmacokinet, 2014,53(9) :801-811.
  • 6Greiner C, Hiemke C, Bader W, et al. Determination of citalopram and escitalopram together with their active main metabolites desmethyl (es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2007,848(2) :391-394.
  • 7马丽娜,李耘,冯明,钱玉英.抑郁对老年高血压患者生命质量的影响[J].中华实用诊断与治疗杂志,2011,25(10):953-954. 被引量:12
  • 8范志雄,谢和辉.抑郁症的药物治疗进展[J].药学实践杂志,2012,30(3):178-181. 被引量:13
  • 9许伟.脑靶向鼻腔给药的研究进展[J].沈阳药科大学学报,2012,29(7):575-580. 被引量:18
  • 10黄天文,文隽,潘文,李艳,雷宇.2种西酞普兰制剂的人体生物等效性研究[J].中国药房,2012,23(34):3214-3216. 被引量:2

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部